# Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate

> **NCT05899751** · — · UNKNOWN · sponsor: **Protherics Medicines Development Limited** · enrollment: 1000 (estimated)

## Conditions studied

- Acute Kidney Injury
- Drug Toxicity

## Interventions

- **DRUG:** High-dose methotrexate
- **DRUG:** Glucarpidase

## Key facts

- **NCT ID:** NCT05899751
- **Lead sponsor:** Protherics Medicines Development Limited
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-01
- **Primary completion:** 2024-08
- **Final completion:** 2024-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-05-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05899751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05899751, "Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05899751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*